MyFinsight
Home
Blog
About
Contact
Back
Income Statement
NewAmsterdam Pharma Co N.V. (NAMS)
NewAmsterdam Pharma Co N.V. (NAMS)
source: myfinsight.com
Download
Download image
Total comprehensive
loss for the year, net...
-$49,013K
(-23.90%↓ Y/Y)
Loss for the year
-$48,441K
(-22.55%↓ Y/Y)
Unrealized gain/(loss) on
available-for-sale securities, net...
-$572K
(-1633.33%↓ Y/Y)
Loss before tax
-$48,441K
(-22.55%↓ Y/Y)
Fair value change -
warrants
-$5,942K
(56.82%↑ Y/Y)
Interest income
$5,650K
(-23.14%↓ Y/Y)
Supply revenue
$3,040K
Operating loss
-$58,420K
(15.24%↑ Y/Y)
Revenue
$3,040K
(2.08%↑ Y/Y)
Foreign exchange
losss/(gaines)
-$1,613K
(-137.57%↓ Y/Y)
Total operating
expenses
$61,460K
(-14.52%↓ Y/Y)
Research and development
expenses
$38,009K
(-15.07%↓ Y/Y)
Selling, general and
administrative expenses
$23,451K
(-13.63%↓ Y/Y)
Back